These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23583545)

  • 21. Developing high-throughput HIV incidence assay with pyrosequencing platform.
    Park SY; Goeken N; Lee HJ; Bolan R; Dubé MP; Lee HY
    J Virol; 2014 Mar; 88(5):2977-90. PubMed ID: 24371062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.
    Murillo W; Lorenzana de Rivera I; Albert J; Guardado ME; Nieto AI; Paz-Bailey G
    J Med Virol; 2012 Oct; 84(10):1514-21. PubMed ID: 22930496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Rates of Transmitted Drug Resistance Among Newly Identified HIV-1 Seroconverters in Rural Rakai, Uganda.
    Reynolds SJ; Ssempijja V; Galiwango R; Ndyanabo A; Nakigozi G; Lyagoba F; Nazziwa J; Redd A; Lamers SL; Gray R; Wawer M; Serwadda D; Quinn TC
    AIDS Res Hum Retroviruses; 2017 May; 33(5):448-451. PubMed ID: 27798967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China.
    Zhang J; Guo Z; Yang J; Pan X; Jiang J; Ding X; Zhang W; Xia Y; Xu Y; Huang J
    J Med Virol; 2015 Oct; 87(10):1668-76. PubMed ID: 25899877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV genotypes and primary drug resistance among HIV-seropositive blood donors in Brazil: role of infected blood donors as sentinel populations for molecular surveillance of HIV.
    Alencar CS; Sabino EC; Carvalho SM; Leao SC; Carneiro-Proietti AB; Capuani L; Oliveira CL; Carrick D; Birch RJ; Gonçalez TT; Keating S; Swanson PA; Hackett J; Busch MP;
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):387-92. PubMed ID: 23507660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P. R. China.
    Zhong P; Kang L; Pan Q; Konings F; Burda S; Ma L; Xue Y; Zheng X; Jin Z; Nyambi P
    J Acquir Immune Defic Syndr; 2003 Sep; 34(1):91-101. PubMed ID: 14501800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
    de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
    Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.
    Gianella S; Delport W; Pacold ME; Young JA; Choi JY; Little SJ; Richman DD; Kosakovsky Pond SL; Smith DM
    J Virol; 2011 Aug; 85(16):8359-67. PubMed ID: 21632754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy.
    Lihana RW; Khamadi SA; Lubano K; Lwembe R; Kiptoo MK; Lagat N; Kinyua JG; Okoth FA; Songok EM; Makokha EP; Ichimura H
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1211-7. PubMed ID: 19954302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
    Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
    Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.
    Rossetti B; Di Giambenedetto S; Torti C; Postorino MC; Punzi G; Saladini F; Gennari W; Borghi V; Monno L; Pignataro AR; Polilli E; Colafigli M; Poggi A; Tini S; Zazzi M; De Luca A;
    HIV Med; 2018 Oct; 19(9):619-628. PubMed ID: 29932313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance.
    Kousiappa I; van de Vijver DA; Demetriades I; Kostrikis LG
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):23-35. PubMed ID: 19182918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.
    Quiñones-Mateu ME; Albright JL; Mas A; Soriano V; Arts EJ
    J Virol; 1998 Nov; 72(11):9002-15. PubMed ID: 9765445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.
    Alcântara KC; Lins JB; Albuquerque M; Aires LM; Cardoso LP; Minuzzi AL; Stefani MM
    J Clin Virol; 2012 May; 54(1):15-20. PubMed ID: 22317908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence editing by Apolipoprotein B RNA-editing catalytic component [corrected] and epidemiological surveillance of transmitted HIV-1 drug resistance.
    Gifford RJ; Rhee SY; Eriksson N; Liu TF; Kiuchi M; Das AK; Shafer RW
    AIDS; 2008 Mar; 22(6):717-25. PubMed ID: 18356601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transmission of drug-resistant HIV-1 variants among individuals with recent infection in southern Poland.
    Smoleń-Dzirba J; Rosińska M; Kruszyński P; Bratosiewicz-Wąsik J; Janiec J; Beniowski M; Bociąga-Jasik M; Jabłonowska E; Szetela B; Wąsik TJ
    Curr HIV Res; 2013 Jun; 11(4):288-94. PubMed ID: 23822819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis on HIV-1 genetics and threshold of drug resistance in Dehong prefecture of Yunnan province in 2013].
    Ma Y; Wang J; Xing H; Chen M; Yao S; Chen H; Yang J; Li Y; Duan S; Jia M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jun; 36(6):584-8. PubMed ID: 26564629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy.
    Hué S; Clewley JP; Cane PA; Pillay D
    AIDS; 2004 Mar; 18(5):719-28. PubMed ID: 15075506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.